← All trials
NCT05176197
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 9, 2022
- Primary completion
- Jun 30, 2023
- Completion date
- Nov 30, 2023
- First posted
- Jan 4, 2022
- Last posted
- Apr 19, 2022
- Enrollment
- 84
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Purdue UniversityLead sponsor
- Purdue UniversityOverall official - principal investigator
- Purdue UniversityReponsible party - principal investigator
- Almond Board of CaliforniaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.